DE SB162

Allows authorized entities (restaurants, sports venues, camps, amusement parks, recreation areas) to obtain prescriptions for and stock epinephrine auto-injectors for emergency use.

Permits trained employees or agents to provide or administer epinephrine auto-injectors to any individual believed to be experiencing anaphylaxis, regardless of prior diagnosis or prescription.

Requires employees and agents to complete anaphylaxis training covering symptom recognition, proper storage and administration procedures, and emergency follow-up before handling epinephrine auto-injectors.

Provides civil liability immunity for persons and entities involved in providing emergency care with epinephrine auto-injectors, except in cases of willful or wanton misconduct or gross negligence.

Requires authorized entities to report each incident of epinephrine auto-injector administration to the Department of Health and Social Services, which must publish an annual summary report.